A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
Clinical trial NCT06342908 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06342908
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2027-03-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.